Association of CYP2B6 (G15631T) polymorphism with Clopidogrel resistance and genetic predisposition to Acute Coronary Syndromes (ACSs) in Morocco

Genetic profiling before adoption of a therapeutic strategy appears to be very useful to identify patients at increased risk for developing cardiovascular events, and may help to choose the most reliable antiplatelet strategy for each patient. The current findings might be preliminary but promising in such field not yet well developed, especially in Moroccan population.